Brooks Laboratories Limited (BOM:533543)
India · Delayed Price · Currency is INR 61.88
+2.48 (4.18%)
At close: Aug 21, 2026
Brooks Laboratories Market Cap
Brooks Laboratories has a market cap or net worth of 1.77 billion as of August 21, 2026. Its market cap has decreased by -60.96% in one year.
Market Cap
1.77B
Enterprise Value
1.79B
Revenue
831.87M
Ranking
n/a
PE Ratio
13.38
Stock Price
61.88
ChartMarket Cap Chart
Since September 5, 2011, Brooks Laboratories's market cap has increased from 105.21M to 1.77B, an increase of 1,579.88%. That is a compound annual growth rate of 20.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 1.77B | -25.13% |
| Dec 31, 2025 | 2.36B | -50.07% |
| Dec 31, 2024 | 4.73B | 25.45% |
| Dec 29, 2023 | 3.77B | 39.59% |
| Dec 30, 2022 | 2.70B | 8.92% |
| Dec 31, 2021 | 2.48B | 51.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxygenta Pharmaceutical | 2.49B |
| Sanjivani Paranteral | 2.39B |
| Coral Laboratories | 2.38B |
| Accretion Pharmaceuticals | 2.31B |
| Bilcare | 2.26B |
| Bio Medica Laboratories | 1.95B |
| Sat Kartar Life | 1.84B |
| Speciality Medicines | 1.38B |